American Healthcare Reit, Inc. (AHR) — SEC Filings
American Healthcare Reit, Inc. (AHR) — 50 SEC filings. Latest: 4 (Apr 8, 2026). Includes 31 8-K, 6 10-Q, 6 SC 13G.
View American Healthcare Reit, Inc. on SEC EDGAR
Overview
American Healthcare Reit, Inc. (AHR) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 4 filed on Apr 8, 2026: On April 8, 2026, American Healthcare REIT, Inc. filed a Form 4, reporting changes in beneficial ownership of securities. The filing pertains to transactions that occurred on April 6, 2026. Specific details regarding the nature of the transactions, the number of shares involved, and the individuals
Sentiment Summary
Across 50 filings, the sentiment breakdown is: 1 bearish, 47 neutral, 2 mixed. The dominant filing sentiment for American Healthcare Reit, Inc. is neutral.
Filing Type Overview
American Healthcare Reit, Inc. (AHR) has filed 1 4, 31 8-K, 6 10-Q, 2 DEF 14A, 2 10-K, 6 SC 13G, 2 SC 13G/A with the SEC between Jan 2024 to Apr 2026.
Filings by Year
Recent SEC Filings (50)
Risk Profile
Risk Assessment: Of AHR's 37 recent filings, 1 were flagged as high-risk, 15 as medium-risk, and 21 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $1.656B |
| Net Income | $59.878M |
| EPS | $0.36 |
| Debt-to-Equity | 0.75 |
| Cash Position | $147.364M |
| Operating Margin | N/A |
| Total Assets | $4.770B |
| Total Debt | $1.875B |
Industry Context
American Healthcare REIT, Inc. operates within the specialized healthcare real estate sector, which is characterized by long-term leases with healthcare providers. The industry is influenced by demographic trends, particularly an aging population, and evolving healthcare regulations and reimbursement models. REITs in this space typically focus on senior housing, skilled nursing facilities, and medical office buildings, requiring stable tenant relationships and efficient property management.
Top Tags
disclosure (6) · financial-reporting (6) · 8-K (6) · corporate-governance (6) · real-estate (6) · financials (5) · REIT (5) · 10-Q (4) · material-agreement (3) · operations (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| SEC File Number | 001-41951 | Identifies the company's filing with the SEC |
| IRS Employer Identification No. | 472887436 | Company's tax identification number |
| Net Income | $59.878M | For the nine months ended September 30, 2025, a significant improvement from a $3.171M loss in 2024. |
| Total Revenues | $1.656B | For the nine months ended September 30, 2025, up from $1.527B in 2024, indicating strong top-line growth. |
| Real Estate Investments, Net | $3.598B | As of September 30, 2025, an increase from $3.366B at December 31, 2024, reflecting asset growth. |
| Acquisitions of Real Estate Investments | $340.401M | For the nine months ended September 30, 2025, a substantial increase from $52.107M in 2024, showing aggressive expansion. |
| Impairment of Real Estate Investments | $38.133M | For the nine months ended September 30, 2025, a new charge compared to zero in 2024, indicating potential asset quality issues. |
| Cash and Cash Equivalents | $147.364M | As of September 30, 2025, nearly double the $76.702M at December 31, 2024, improving liquidity. |
| Interest Expense, Net | $65.969M | For the nine months ended September 30, 2025, down from $97.429M in 2024, reducing financial burden. |
| Diluted EPS | $0.36 | For the nine months ended September 30, 2025, a positive shift from a ($0.05) loss in 2024. |
| Common Stock Shares Outstanding | 171,031,062 | As of September 30, 2025, an increase from 157,446,697 at December 31, 2024, due to offerings. |
| Distributions Declared | $124.277M | For the nine months ended September 30, 2025, an increase from $104.530M in 2024, reflecting shareholder returns. |
| Net Loss (Q2 2025) | $10.2M | Increased from $6.8M in Q2 2024, indicating worsening profitability. |
| Total Revenues (Q2 2025) | $145.3M | Slight decrease from $146.1M in Q2 2024, showing stagnant top-line growth. |
| Net Loss (YTD Q2 2025) | $20.1M | Higher than $13.5M for YTD Q2 2024, reflecting sustained losses. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for American Healthcare Reit, Inc. (AHR)?
American Healthcare Reit, Inc. has 50 recent SEC filings from Jan 2024 to Apr 2026, including 31 8-K, 6 10-Q, 6 SC 13G. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of AHR filings?
Across 50 filings, the sentiment breakdown is: 1 bearish, 47 neutral, 2 mixed. The dominant sentiment is neutral.
Where can I find American Healthcare Reit, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all American Healthcare Reit, Inc. (AHR) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for American Healthcare Reit, Inc.?
Key financial highlights from American Healthcare Reit, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for AHR?
The investment thesis for AHR includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at American Healthcare Reit, Inc.?
Executive information for American Healthcare Reit, Inc. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for American Healthcare Reit, Inc. stock?
Of AHR's 37 assessed filings, 1 were flagged high-risk, 15 medium-risk, and 21 low-risk.
What are recent predictions and forward guidance from American Healthcare Reit, Inc.?
Forward guidance and predictions for American Healthcare Reit, Inc. are extracted from SEC filings as they are enriched.